FRRS1
gene geneOn this page
Also known as SDR2
Summary
FRRS1 (ferric chelate reductase 1, HGNC:27622) is a protein-coding gene on chromosome 1p21.2, encoding Ferric reductase 1 (Q6ZNA5). Ferric reductase that reduces Fe(3+) to Fe(2+) and could play a role in iron import into cells.
Members of the cytochrome b561 (CYB561; MIM 600019) family, including FRRS1, reduce ferric to ferrous iron before its transport from the endosome to the cytoplasm (Vargas et al., 2003 [PubMed 14499595]).
Source: NCBI Gene 391059 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 99 total
- MANE Select transcript:
NM_001361041
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27622 |
| Approved symbol | FRRS1 |
| Name | ferric chelate reductase 1 |
| Location | 1p21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SDR2 |
| Ensembl gene | ENSG00000156869 |
| Ensembl biotype | protein_coding |
| OMIM | 611578 |
| Entrez | 391059 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000287474, ENST00000370176, ENST00000489209, ENST00000492943, ENST00000646001, ENST00000852116
RefSeq mRNA: 2 — MANE Select: NM_001361041
NM_001013660, NM_001361041
CCDS: CCDS30780, CCDS91007
Canonical transcript exons
ENST00000646001 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001028788 | 99738086 | 99738268 |
| ENSE00001028790 | 99740793 | 99740940 |
| ENSE00001067082 | 99717410 | 99717525 |
| ENSE00001067083 | 99719534 | 99719647 |
| ENSE00001067089 | 99728493 | 99728640 |
| ENSE00001167676 | 99742179 | 99742273 |
| ENSE00001167685 | 99747294 | 99747430 |
| ENSE00001312396 | 99729650 | 99729748 |
| ENSE00001768513 | 99748573 | 99748768 |
| ENSE00001974441 | 99748897 | 99749001 |
| ENSE00003536712 | 99715586 | 99715672 |
| ENSE00003577059 | 99712418 | 99712515 |
| ENSE00003605771 | 99712105 | 99712163 |
| ENSE00003816219 | 99703970 | 99709120 |
| ENSE00003823692 | 99766607 | 99766635 |
| ENSE00003828763 | 99710806 | 99710949 |
| ENSE00003830969 | 99709198 | 99709259 |
Expression profiles
Bgee: expression breadth ubiquitous, 207 present calls, max score 90.29.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5049 / max 61.8116, expressed in 1230 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 13494 | 3.5049 | 1230 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 90.29 | silver quality |
| liver | UBERON:0002107 | 88.03 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 83.27 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.69 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 82.04 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 82.00 | gold quality |
| skin of abdomen | UBERON:0001416 | 81.66 | gold quality |
| colonic epithelium | UBERON:0000397 | 81.29 | gold quality |
| skin of leg | UBERON:0001511 | 81.21 | gold quality |
| esophagus mucosa | UBERON:0002469 | 81.20 | gold quality |
| zone of skin | UBERON:0000014 | 80.96 | gold quality |
| vagina | UBERON:0000996 | 79.98 | gold quality |
| upper arm skin | UBERON:0004263 | 79.73 | silver quality |
| ectocervix | UBERON:0012249 | 79.44 | gold quality |
| corpus epididymis | UBERON:0004359 | 79.14 | gold quality |
| gingival epithelium | UBERON:0001949 | 78.55 | gold quality |
| gingiva | UBERON:0001828 | 78.28 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.55 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.39 | gold quality |
| upper leg skin | UBERON:0004262 | 76.95 | gold quality |
| placenta | UBERON:0001987 | 76.85 | gold quality |
| oral cavity | UBERON:0000167 | 76.83 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 76.83 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.46 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.07 | gold quality |
| uterine cervix | UBERON:0000002 | 75.98 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 75.84 | gold quality |
| adrenal gland | UBERON:0002369 | 75.62 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 75.18 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 6.09 |
| E-MTAB-9801 | no | 3.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting FRRS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-4273 | 99.45 | 67.93 | 1206 |
| HSA-MIR-1912-3P | 99.32 | 67.40 | 936 |
| HSA-MIR-1295B-5P | 99.03 | 67.50 | 810 |
| HSA-MIR-3124-3P | 98.87 | 68.95 | 2123 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
| HSA-MIR-2117 | 98.48 | 67.97 | 1307 |
| HSA-MIR-34C-3P | 98.11 | 65.60 | 858 |
| HSA-MIR-5585-5P | 97.95 | 68.80 | 1024 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-3667-5P | 97.16 | 64.87 | 591 |
| HSA-MIR-4761-3P | 96.27 | 66.26 | 524 |
| HSA-MIR-4509 | 96.19 | 65.80 | 900 |
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | frrs1a | ENSDARG00000076183 |
| danio_rerio | frrs1b | ENSDARG00000077605 |
| mus_musculus | Frrs1 | ENSMUSG00000033386 |
| rattus_norvegicus | Frrs1 | ENSRNOG00000016351 |
| drosophila_melanogaster | CG8399 | FBGN0034067 |
| drosophila_melanogaster | CG14515 | FBGN0039648 |
| drosophila_melanogaster | l(2)34Fc | FBGN0261534 |
| caenorhabditis_elegans | WBGENE00007339 | |
| caenorhabditis_elegans | WBGENE00007545 | |
| caenorhabditis_elegans | WBGENE00013292 | |
| caenorhabditis_elegans | WBGENE00019746 | |
| caenorhabditis_elegans | WBGENE00077490 |
Paralogs (2): REELD1 (ENSG00000250673), FRRS1L (ENSG00000260230)
Protein
Protein identifiers
Ferric reductase 1 — Q6ZNA5 (reviewed: Q6ZNA5)
Alternative names: Ferric-chelate reductase 1, Stromal cell-derived receptor 2
All UniProt accessions (1): Q6ZNA5
UniProt curated annotations — full annotation on UniProt →
Function. Ferric reductase that reduces Fe(3+) to Fe(2+) and could play a role in iron import into cells. The electron donor and therefore the reaction mechanism are not known.
Subcellular location. Membrane.
Cofactor. Binds 2 heme b groups non-covalently.
Similarity. Belongs to the FRRS1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZNA5-1 | 1 | yes |
| Q6ZNA5-2 | 2 |
RefSeq proteins (2): NP_001013682, NP_001347970* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002861 | Reeler_dom | Domain |
| IPR005018 | DOMON_domain | Domain |
| IPR006593 | Cyt_b561/ferric_Rdtase_TM | Domain |
| IPR042307 | Reeler_sf | Homologous_superfamily |
| IPR051237 |
Pfam: PF02014, PF03351
UniProt features (20 total): transmembrane region 7, binding site 4, domain 3, glycosylation site 3, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZNA5-F1 | 88.49 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 373 (axial binding residue); 414 (axial binding residue); 446 (axial binding residue); 482 (axial binding residue)
Glycosylation sites (3): 138, 308, 321
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 139 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS, LA_MEN1_TARGETS, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GROSS_HYPOXIA_VIA_HIF1A_UP, GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GOBP_MONOATOMIC_ION_HOMEOSTASIS, BASAKI_YBX1_TARGETS_DN, LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP, chr1p21, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS, CHEN_METABOLIC_SYNDROM_NETWORK
GO Biological Process (1): intracellular iron ion homeostasis (GO:0006879)
GO Molecular Function (3): oxidoreductase activity, acting on metal ions (GO:0016722), metal ion binding (GO:0046872), oxidoreductase activity (GO:0016491)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular monoatomic cation homeostasis | 1 |
| inorganic ion homeostasis | 1 |
| oxidoreductase activity | 1 |
| cation binding | 1 |
| catalytic activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FRRS1 | CYB561 | P49447 | 956 |
| FRRS1 | HPX | P02790 | 774 |
| FRRS1 | CYB561D2 | O14569 | 622 |
| FRRS1 | HSD17B14 | Q9BPX1 | 507 |
| FRRS1 | CYBRD1 | Q53TN4 | 507 |
| FRRS1 | CYB561A3 | Q8NBI2 | 478 |
| FRRS1 | SPDYE2 | Q495Y8 | 417 |
| FRRS1 | PALMD | Q9NP74 | 412 |
| FRRS1 | SPATA45 | Q537H7 | 396 |
| FRRS1 | OR6K3 | Q8NGY3 | 396 |
| FRRS1 | CD109 | Q6YHK3 | 366 |
| FRRS1 | SLC11A2 | P49281 | 358 |
| FRRS1 | ZNF841 | Q6ZN19 | 352 |
| FRRS1 | SLC39A14 | Q15043 | 348 |
| FRRS1 | PLPPR4 | Q7Z2D5 | 323 |
IntAct
0 interactions, top by confidence:
BioGRID (2): FRRS1 (Proximity Label-MS), FRRS1 (Proximity Label-MS)
ESM2 similar proteins: A0A0G2K1Q8, A2VE04, A4QP81, G5ECB2, O08680, O13146, O62714, O75899, O88871, O88917, O88923, O94910, O95490, O97817, O97827, O97831, P29319, P35384, P48442, P54755, P54757, P54758, Q07497, Q21540, Q5TZ24, Q5U9X3, Q61703, Q62413, Q6INU7, Q6ZNA5, Q7TT41, Q80T41, Q80TR1, Q80TS3, Q8BG22, Q8BXJ9, Q8C7U7, Q8JZZ7, Q8K385, Q8MSU3
Diamond homologs: A0A1B0GV85, A2VE04, P0C963, Q0Q028, Q0Q029, Q5MGQ0, Q6INU7, Q6ZNA5, Q765V4, Q86RS3, Q8K385, Q9V3Y3, A4QP81, B1AXV0, D3ZE85, P35446, P35447, Q8VCC9, Q9GLX9, Q9HCB6, Q9P0K9, Q9W770, Q008X1, O96382, Q8MSU3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
99 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 84 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2891 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:99709193:CTTA:C | donor_loss | 1.0000 |
| 1:99709195:TA:T | donor_loss | 1.0000 |
| 1:99709196:ACCTC:A | donor_loss | 1.0000 |
| 1:99709255:TTCAA:T | acceptor_gain | 1.0000 |
| 1:99709256:TCAA:T | acceptor_gain | 1.0000 |
| 1:99709257:CAA:C | acceptor_gain | 1.0000 |
| 1:99709257:CAAC:C | acceptor_gain | 1.0000 |
| 1:99709258:AA:A | acceptor_gain | 1.0000 |
| 1:99709258:AACT:A | acceptor_loss | 1.0000 |
| 1:99709259:ACTG:A | acceptor_loss | 1.0000 |
| 1:99709260:C:CC | acceptor_gain | 1.0000 |
| 1:99709260:CT:C | acceptor_loss | 1.0000 |
| 1:99709261:T:A | acceptor_loss | 1.0000 |
| 1:99709264:C:CT | acceptor_gain | 1.0000 |
| 1:99710835:T:TA | donor_gain | 1.0000 |
| 1:99710945:TGCCA:T | acceptor_gain | 1.0000 |
| 1:99710947:CCA:C | acceptor_gain | 1.0000 |
| 1:99710948:CA:C | acceptor_gain | 1.0000 |
| 1:99710948:CAC:C | acceptor_gain | 1.0000 |
| 1:99710950:C:CC | acceptor_gain | 1.0000 |
| 1:99710954:A:C | acceptor_gain | 1.0000 |
| 1:99710957:C:CT | acceptor_gain | 1.0000 |
| 1:99712161:CTT:C | acceptor_gain | 1.0000 |
| 1:99712164:C:CC | acceptor_gain | 1.0000 |
| 1:99712168:C:CT | acceptor_gain | 1.0000 |
| 1:99712413:AGTAC:A | donor_loss | 1.0000 |
| 1:99712414:GTA:G | donor_loss | 1.0000 |
| 1:99712415:TA:T | donor_loss | 1.0000 |
| 1:99712417:C:A | donor_loss | 1.0000 |
| 1:99712514:TG:T | acceptor_gain | 1.0000 |
AlphaMissense
3915 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:99710863:A:G | W523R | 0.988 |
| 1:99710863:A:T | W523R | 0.988 |
| 1:99717488:G:C | S386R | 0.988 |
| 1:99717488:G:T | S386R | 0.988 |
| 1:99717490:T:G | S386R | 0.988 |
| 1:99742259:A:C | S116R | 0.987 |
| 1:99742259:A:T | S116R | 0.987 |
| 1:99742261:T:G | S116R | 0.987 |
| 1:99747345:G:C | F94L | 0.985 |
| 1:99747345:G:T | F94L | 0.985 |
| 1:99747347:A:G | F94L | 0.985 |
| 1:99742182:A:G | F142S | 0.982 |
| 1:99747400:A:G | F76S | 0.982 |
| 1:99728591:C:G | C303S | 0.981 |
| 1:99728592:A:T | C303S | 0.981 |
| 1:99747399:A:C | F76L | 0.981 |
| 1:99747399:A:T | F76L | 0.981 |
| 1:99747401:A:G | F76L | 0.981 |
| 1:99728592:A:G | C303R | 0.980 |
| 1:99747346:A:G | F94S | 0.979 |
| 1:99742217:C:A | W130C | 0.977 |
| 1:99742217:C:G | W130C | 0.977 |
| 1:99717505:A:G | W381R | 0.976 |
| 1:99717505:A:T | W381R | 0.976 |
| 1:99740932:A:T | V146D | 0.976 |
| 1:99742219:A:G | W130R | 0.976 |
| 1:99742219:A:T | W130R | 0.976 |
| 1:99747397:A:G | L77P | 0.975 |
| 1:99717464:G:C | F394L | 0.974 |
| 1:99717464:G:T | F394L | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000008487 (1:99704658 G>A), RS1000050906 (1:99743115 T>A,C), RS1000095837 (1:99706668 T>G), RS1000106892 (1:99749524 T>C), RS1000130434 (1:99752609 T>C), RS1000151011 (1:99712339 T>C), RS1000152920 (1:99756700 A>G), RS1000207488 (1:99747165 T>C), RS1000210455 (1:99704974 G>A), RS1000221461 (1:99712823 G>A), RS1000359510 (1:99704842 G>C), RS1000403168 (1:99737804 A>G), RS1000469025 (1:99719096 G>A,C), RS1000553735 (1:99711232 T>A,C), RS1000566131 (1:99732601 T>C,G)
Disease associations
OMIM: gene MIM:611578 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001764_6 | White matter integrity (bipolar disorder risk interaction) | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004641 | white matter integrity |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Naled | affects expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Cyclosporine | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.